BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 10754415)

  • 1. Cytomegalovirus infection in a seroendemic renal transplant population: a longitudinal study of virological markers.
    Rao M; Finny GJ; Abraham P; Juneja R; Thomas PP; Jacob CK; Sridharan G
    Nephron; 2000 Apr; 84(4):367-73. PubMed ID: 10754415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
    Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
    Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG).
    Hassan-Walker AF; Kidd IM; Sabin C; Sweny P; Griffiths PD; Emery VC
    J Med Virol; 1999 Jun; 58(2):182-7. PubMed ID: 10335868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of cytomegalovirus (CMV) disease in renal allograft recipients: the role of semiquantitative polymerase chain reaction (PCR).
    Peiris JS; Taylor CE; Main J; Graham K; Madeley CR
    Nephrol Dial Transplant; 1995; 10(7):1198-205. PubMed ID: 7478124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.
    Toyoda M; Carlos JB; Galera OA; Galfayan K; Zhang X; Sun Z; Czer LS; Jordan SC
    Transplantation; 1997 Apr; 63(7):957-63. PubMed ID: 9112347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and practical value of human cytomegalovirus DNAemia detection by semi-nested PCR for follow-up of BMT recipients.
    Imbert-Marcille BM; Milpied N; Coste-Burel M; Richet B; Moreau P; Harousseau JL; Billaudel S
    Bone Marrow Transplant; 1995 Apr; 15(4):611-7. PubMed ID: 7655389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?
    Osman HK; Peiris JS; Taylor CE; Warwicker P; Jarrett RF; Madeley CR
    J Med Virol; 1996 Apr; 48(4):295-301. PubMed ID: 8699160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation.
    Drouet E; Colimon R; Michelson S; Fourcade N; Niveleau A; Ducerf C; Boibieux A; Chevallier M; Denoyel G
    J Clin Microbiol; 1995 Feb; 33(2):389-94. PubMed ID: 7714198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy.
    Brennan DC; Garlock KA; Lippmann BA; Buller RS; Gaudreault-Keener M; Lowell JA; Miller SB; Shenoy S; Howard TK; Storch GA
    J Am Soc Nephrol; 1997 Jan; 8(1):118-25. PubMed ID: 9013456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.
    Gerna G; Baldanti F; Lilleri D; Parea M; Alessandrino E; Pagani A; Locatelli F; Middeldorp J; Revello MG
    J Clin Microbiol; 2000 May; 38(5):1845-53. PubMed ID: 10790111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of the predictive value of polymerase chain reaction assay for cytomegalovirus in asymptomatic kidney transplant recipients.
    Benedetti E; Mihalov M; Asolati M; Kirby J; Dunn T; Raofi V; Fontaine M; Pollak R
    Clin Transplant; 1998 Oct; 12(5):391-5. PubMed ID: 9787946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antibody response to human cytomegalovirus in Indian renal transplant patients.
    Finny GJ; Rao M; Mach M; Juneja R; Thomas PP; Jacob CK; Manayani DJ; Abraham P; Abraham M; Sridharan G
    Indian J Med Res; 2001 Jun; 113():221-7. PubMed ID: 11816956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymerase chain reaction as a rapid diagnostic assay for cytomegalovirus infection in renal transplant patients.
    Lisby G; Dessau RB; Andersen CB; Ladefoged S
    APMIS; 1994 Sep; 102(9):690-4. PubMed ID: 7946272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring human cytomegalovirus viral load in peripheral blood leukocytes of renal transplant recipients by a simple limiting dilution-PCR assay.
    Caballero OL; Costa MC; Trevisan A; Oliveira RM; Viotti EA; Távora ER; Vilaça SS; Sabagga E; De-Paula FJ; Távora PF; Brasileiro-Filho G; Villa LL; Simpson AJ
    Braz J Med Biol Res; 1999 Dec; 32(12):1515-23. PubMed ID: 10585633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
    Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
    J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the detection of viral DNA by the polymerase chain reaction in peripheral blood leukocytes and serological responses to human herpesvirus 6, human herpesvirus 7, and cytomegalovirus in renal allograft recipients.
    Osman HK; Peiris JS; Taylor CE; Karlberg JP; Madeley CR
    J Med Virol; 1997 Nov; 53(3):288-94. PubMed ID: 9365898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of cytomegalovirus DNA in sera using the polymerase chain reaction: relationship with clinical diagnosis of cytomegalovirus infection after renal transplantation.
    Yamamoto T; Nakajima Y; Hironaka T; Hirai K; Nakamura Y
    Nephron; 1995; 70(1):100-3. PubMed ID: 7617086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation.
    Pouteil-Noble C; Ecochard R; Bosshard S; Lacavalerie B; Donia A; Landrivon G; Tardy JC; Dubernard JM; Aymard M; Touraine JL
    Transpl Int; 1992; 5 Suppl 1():S26-9. PubMed ID: 14621724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.